Skip to content
News & Events
Advertising & Media
Entertainment, Music & Sports
Corporate & Finance
Investigations & Compliance
Privacy, Security & Data Innovations
Restructuring & Bankruptcy
Trusts & Estates
View All Practices & Industries
Rights Offering for Opexa Therapeutics, Inc.
Represented Maxim Group LLC as lead dealer-manager and National Securities Corporation as co-dealer-manager in a $13.8 million rights offering for Opexa Therapeutics, Inc., a NASDAQ-listed biotechnology company.
John F. Settineri
Mitchell S. Nussbaum
Vice Chair, Loeb & Loeb LLP; Co-Chair, Capital Markets and Corporate
Norwood P. Beveridge Jr.
View Less Related Professionals
View More Related Professionals
SEC Issues Report Regarding Cyber Related Frauds; Launches FinHub
Loeb & Loeb advises China Grand Pharmaceutical on HK$2.05 billion non-underwritten rights issue
Awards and Accolades
36 Loeb & Loeb Attorneys Recognized in 2018 New York Metro Super Lawyers and 13 Selected as Rising Stars
Infocast's Annual Projects & Money 2019 Conference